ARCHIVES

Enzalutamide Reduced Risk of Progression By 81 Percent in Metastatic Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

Interview with Mark Ratain: Too Much Emphasis On Precision, Not Enough Emphasis On Accuracy In Dosing

October 8, 2010

New Firm Steps Onto Texas Battleground for Control Over Office-Based Oncology

November 22, 1996

Diagnosis-Treatment Cidac contract Gets Recompetition Okay

December 16, 1983

Mason Asks For Better Technology Transfer In Cancer Prevention

October 30, 1992

Nelson Elected ACCC Veep

February 13, 1976

NIH grant success rate drops to under 20 percent after 2011 budget cuts

May 13, 2011